Organization & Developments: Hememics

Parents

HeMemics Biotechnology Inc., in collaboration with the US Army, to study the oxygen carrying capacity of its desiccated red blood cells.
HeMemics has a desiccation technology that can be applied to many peptides, proteins, cell types and possibly thin tissues.
Perishable biologics preserved using the HeMeDri™ technology are stable at cold or ambient temperatures, allowing wider distribution of temperature-sensitive biologics with minimal cold chain management.
The biologics are maintained and preserved in the desiccated state and functions return upon reconstitution.